Post Categories
QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells
QPS and Samsara Sciences have solidified a cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and…
QPS Now Has Exclusive Distribution Rights for Samsara’s Specialized Human Liver Cells
March 25, 2016
QPS and Samsara Sciences have solidified a cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and…
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th. Several members of QPS’ Early Phase Clinical team will be…
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th
March 9, 2016
QPS will have a strong presence at ASCPT 2016 in San Diego March 9th-11th. Several members of QPS’ Early Phase Clinical team will be…
QPS is proud to announce that our toxicology facility passed a GLP audit by the US FDA in 3Q 2015 with no major findings.
We are exhibiting at SOT 55th Annual Meeting and ToxExpoTM. Please visit our booth (#1813) between March 13-16 at the New Orleans Convention Center,…
QPS is proud to announce that our toxicology facility passed a GLP audit by the US FDA in 3Q 2015 with no major findings.
March 7, 2016
We are exhibiting at SOT 55th Annual Meeting and ToxExpoTM. Please visit our booth (#1813) between March 13-16 at the New Orleans Convention Center,…
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly…
QPS Global Clinical Operations Team Aces Enrollment for Global Study of Prostate Cancer Drug and Completes the First Patient in Europe!
March 2, 2016
QPS has been assisting an international Sponsor to perform a global, late-phase study to investigate the safety, efficacy, and pharmacokinetic behavior of a newly…
QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study
If you need to quantify blood zinc levels, are working on a gadolinium-based MRI contrast agent, or need to measure platinum levels in mouse…
QPS will create an (LC)-ICP-MS assay to perform the critical elemental analysis in your drug development study
March 1, 2016
If you need to quantify blood zinc levels, are working on a gadolinium-based MRI contrast agent, or need to measure platinum levels in mouse…
QPS Seen As Inspirational for Delaware
Where do you turn when you just took the package? 25% of DuPont employees (likely more on the way) got the bad news here…
QPS Seen As Inspirational for Delaware
February 25, 2016
Where do you turn when you just took the package? 25% of DuPont employees (likely more on the way) got the bad news here…
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and…
Consultation open on revised EMA Guideline on Medicines to treat Alzheimer’s Disease
February 15, 2016
The European Medicines Agency (EMA) has released a draft guideline revision on the clinical investigation of medicines for the treatment of Alzheimer’s disease and…
New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database
The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last…
New ICP-MS Magnesium (Mg) Assays in Human Plasma and Urine added to the QPS Global Assay Database
February 9, 2016
The role of Mg in human nutrition has recently received renewed interest. Mg dietary intake has been reported to have decreased during the last…
See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016
On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development…
See QPS in London at Informa’s Early Clinical Development Conference, 23 – 24 February 2016
February 5, 2016
On February 23, Professor Zuzana Diamant, MD PhD, Director of Respiratory & Allergy Research at QPS, will talk about Biomarkers in Respiratory Drug Development…
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are…
Read the QPS Whitepaper on Phase I Site Selection to support EU Registration
January 6, 2016
Making the right decision about where to conduct Phase I of a clinical trial is crucial. As long as basic EU regulatory requirements are…
Wishing You a Very Happy New Year, With Some Very Cool Science
Cancer immuno therapies. Oligo therapeutics. CAR T-cell therapies. Breakthrough Antivirals. For the past 20 years, we’ve been following the path of solid science and…
Wishing You a Very Happy New Year, With Some Very Cool Science
December 16, 2015
Cancer immuno therapies. Oligo therapeutics. CAR T-cell therapies. Breakthrough Antivirals. For the past 20 years, we’ve been following the path of solid science and…
Just Out! QPS Scientist LingSing Chen Contributes Biosimilars Expertise to eBook
LingSing Chen, PhD, former VP and Global Head of Translational Medicine and Biosimilars at QPS, shares her bioanalytical expertise in a new eBook published…
Just Out! QPS Scientist LingSing Chen Contributes Biosimilars Expertise to eBook
November 16, 2015
LingSing Chen, PhD, former VP and Global Head of Translational Medicine and Biosimilars at QPS, shares her bioanalytical expertise in a new eBook published…
The Flu Shot and COVID: Will the Delta Variant Play a Role?
Cold and flu season is nearly here, with flu activity typically peaking between the months of December and February. But according to a recent…
The Flu Shot and COVID: Will the Delta Variant Play a Role?
November 3, 2021
Cold and flu season is nearly here, with flu activity typically peaking between the months of December and February. But according to a recent…
New Hope for Ultra-Rare Childhood Disease
The recent release of findings from a small Phase 1 clinical trial not only gives hope to families affected by an ultra-rare childhood disease,…
New Hope for Ultra-Rare Childhood Disease
November 1, 2021
The recent release of findings from a small Phase 1 clinical trial not only gives hope to families affected by an ultra-rare childhood disease,…
CRISPR and the Continuing Quest for CAR-T Safety and Durability
CAR-T is an immunotherapy that is currently used to treat blood cancers and is in clinical trials to treat other cancers as well. This…
CRISPR and the Continuing Quest for CAR-T Safety and Durability
October 27, 2021
CAR-T is an immunotherapy that is currently used to treat blood cancers and is in clinical trials to treat other cancers as well. This…
mRNA: Great Expectations vs. Limited Applications
While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19…
mRNA: Great Expectations vs. Limited Applications
October 18, 2021
While research on potential therapeutic applications of mRNA has been underway for more than a decade, the success of the Pfizer and Moderna COVID-19…
Will You Need a COVID-19 Vaccine Booster Shot?
On September 22, 2021, the U.S. Food and Drug Administration (FDA) approved a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific communities….
Will You Need a COVID-19 Vaccine Booster Shot?
October 13, 2021
On September 22, 2021, the U.S. Food and Drug Administration (FDA) approved a single booster dose of the Pfizer-BioNTech COVID-19 vaccine for specific communities….
When COVID-19 Vaccine Supply Doesn’t Meet the Need, Innovations Emerge
It is hard to believe that within one year of the declaration of the pandemic, as many as eleven COVID-19 vaccines received emergency authorized…
When COVID-19 Vaccine Supply Doesn’t Meet the Need, Innovations Emerge
October 11, 2021
It is hard to believe that within one year of the declaration of the pandemic, as many as eleven COVID-19 vaccines received emergency authorized…
At QPS We Believe In Developing Close And Long-Lasting Relationships With Our Clients On The Basis Of Trust And Mutual Respect. This mutual trust,…
Introduction RNA based drugs are a promising new class of therapeutics with tremendous potential for treating a wide range of diseases. There are various…
About Messenger Ribonucleic Acid (mRNA) Current mRNA (messenger ribonucleic acid) research has rapidly driven the discovery and production of this new therapeutic. Modified mRNAs…
NEWARK, Delaware, January 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials,…
NEWARK, Delaware, Dec. 14, 2023/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a global contract research organization (CRO) that provides discovery, preclinical, bioanalysis, clinical trials,…
SPRINGFIELD, Missouri, Dec. 4, 2023/BUSINESS WIRE/ — QPS Holdings, LLC, a global contract research organization, has expanded operations in Springfield, Missouri. The new facilities…